Story perspectives

Tirzepatide Slows Breast Cancer Growth in Obese Mice

9/8/2025

35 3

Summary

Story summary

A preclinical study found that tirzepatide slowed breast cancer tumor growth in obese mice.
Presented at ENDO 2025, the study linked weight loss to reduced cancer progression.
Researchers from the University of Michigan studied 16 mice on a high-fat diet.
Treated mice lost approximately 20% of body weight, leading to significant tumor volume reduction.
Ongoing research will differentiate weight loss effects from tirzepatide's direct impact on tumors.

1 of 1

Story summary

A preclinical study found that tirzepatide slowed breast cancer tumor growth in obese mice.
Presented at ENDO 2025, the study linked weight loss to reduced cancer progression.
Researchers from the University of Michigan studied 16 mice on a high-fat diet.
Treated mice lost approximately 20% of body weight, leading to significant tumor volume reduction.
Ongoing research will differentiate weight loss effects from tirzepatide's direct impact on tumors.